Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2021 Jun 1;87(2):769-775.
doi: 10.1097/QAI.0000000000002646.

Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections

Jade Pagkas-Bather  1 , Christine M Khosropour  1 , Matthew R Golden  1   2   3 , Christina Thibault  3 , Julia C Dombrowski  1   2   3
Affiliations

Population-Level Effectiveness of HIV Pre-exposure Prophylaxis Among MSM and Transgender Persons With Bacterial Sexually Transmitted Infections

Jade Pagkas-Bather et al. J Acquir Immune Defic Syndr. .

Abstract

Background: Pre-exposure prophylaxis (PrEP) is highly efficacious, but its effectiveness may be limited by poor adherence or discontinuation. Our objective was to estimate the effectiveness of real-world PrEP use in a population at increased risk of HIV infection.

Setting: King County, Washington.

Methods: We conducted a retrospective cohort study using sexually transmitted infection (STI) partner services (PS) interview data collected January 2014-August 2018 in King County, Washington, USA. During PS interviews, men who have sex with men and transgender persons who have sex with men were asked if they were taking PrEP. We linked STI PS data to HIV surveillance data to estimate HIV incidence among self-reported PrEP users vs. nonusers using Cox proportional hazards regression, adjusting for age, race/ethnicity, and calendar year.

Results: Among 4368 individuals, 1206 (28%) were taking PrEP at the time of the PS interview. The median observation time was 14 months (interquartile range 6-23 months). Five (0.4%) of 1206 PrEP users and 97 (3%) of 2162 PrEP nonusers were subsequently diagnosed with HIV (P < 0.001). HIV incidence was lower among PrEP users than nonusers [0.17 vs. 1.86 cases per 100 person-years, adjusted hazards ratio 0.21 (95% confidence interval: 0.08 to 0.58)]. Latinx ethnicity, Native Hawaiian/Pacific Islander ethnicity, gonorrhea, and syphilis were also independently associated with higher HIV risk.

Conclusions: Self-reported PrEP use was associated with a 79% reduction in HIV incidence among men who have sex with men and transgender persons who have sex with men with STIs in King County.

PubMed Disclaimer

Conflict of interest statement

J.C.D. has conducted research funded by a grant to the University of Washington from Hologic. C.M.K. has received donations of specimen kits and reagents from Hologic, Inc, for activities outside the submitted work. The remaining authors have no conflicts of interest to disclose.

Figures

FIGURE 1.
FIGURE 1.
Kaplan–Meier curve of HIV acquisition by PrEP status. *aHR, adjusted hazard ratio with respect to race/ethnicity, age, and bacterial STI diagnosis.
See this image and copyright information in PMC

References

    1. Chan PA, Patel RR, Mena L, et al. . Long-term retention in pre-exposure prophylaxis care among men who have sex with men and transgender women in the United States. J Int AIDS Soc. 2019;22:e25385. - PMC - PubMed
    1. Dombrowski JC, Golden MR, Barbee LA, et al. . Patient disengagement from an HIV preexposure prophylaxis program in a sexually transmitted disease clinic. Sex Transm Dis. 2018;45:e62–e64. - PMC - PubMed
    1. Hojilla JC, Vlahov D, Crouch PC, et al. . HIV pre-exposure prophylaxis (PrEP) uptake and retention among men who have sex with men in a community-based sexual health clinic. AIDS Behav. 2018;22:1096–1099. - PMC - PubMed
    1. Liu AY, Cohen SE, Vittinghoff E, et al. . Preexposure prophylaxis for HIV infection integrated with municipal- and community-based sexual health services. JAMA Intern Med. 2016;176:75–84. - PMC - PubMed
    1. Marcus JL, Hurley LB, Hare CB, et al. . Preexposure prophylaxis for HIV prevention in a large integrated health care system: adherence, renal safety, and discontinuation. J Acquir Immune Defic Syndr. 2016;73:540–546. - PMC - PubMed

Publication types

MeSH terms

Substances